EUVIMEDEUVIMED entdecken
Open Access

Cytotoxic CD4 + T Cells in Visceral Leishmaniasis Patients

Shashi Bhushan Chauhan iD, Siddharth Sankar Singh, Bhawana Singh, Shashi Kumar iD, Rahul Tiwari, Vibhav Gautam iD, Fabian Rivera, Susanne Nylen, Christian Engwerda, Shyam Sundar, Rajiv Kumar

Parasite Immunology · 2026-08 · 48 (8)

DOI: 10.1111/pim.70097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasite Immunology, online erschienen am 18.08.2026. Verfasst von Shashi Bhushan Chauhan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Leishmania donovani, CD4-Positive T-Lymphocytes, T-Lymphocytes, Cytotoxic. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral leishmaniasis (VL), a parasitic disease caused by Leishmania donovani , requires a robust CD4 + T‐cells response to control parasite replication by interferon‐gamma (IFN‐γ) production and activation of macrophages. However, in VL patients, the anti‐parasitic CD4 + T‐cell responses are ineffective for reasons that are still unclear. Our recent study reporting a transcriptional signature of CD4 + T‐cell isolated from the peripheral blood of active VL patients showed enhanced expression of genes related to cytotoxicity. This study investigates the cytotoxic potential of CD4 + T‐cells in VL patients, focusing on the expression of the key cytotoxic molecules granzyme B (GZMB), granulysin (GNLY), perforin (PRF), natural killer cell granule protein 7 (NKG7) and the degranulation capacity of CD4 + T‐cells during infection. We observed significant upregulation of these cytotoxic markers in CD4⁺ T‐cells from VL patients, particularly prior to anti‐parasitic drug treatment (D0), suggesting activation of these cells. However, the degranulation capacity, as indicated by CD107a expression, was comparable between VL patients and endemic controls (ECs), suggesting potential functional impairment in the cytotoxic response. Yet, antigen‐specific GZMB secretion in whole blood cultures and intracellular GZMB production in CD4 + T‐cell subsets (notably Th1, Th9 and Th17/22 cells) were enhanced in VL patients, indicating a robust antigen‐specific response, though this did not translate into effective parasite control. These findings highlight a paradox whereby CD4 + T‐cells from VL patients have heightened production of cytotoxic molecules, but lack translocation of CD107a to the cell surface, which is associated with an inability to eliminate parasites. This study provides new insights into the immune dysfunction in VL, highlighting a potential role for the cytotoxic phenotype that develops in parasite‐specific CD4 + T‐cells. Targeting these pathways may offer novel therapeutic strategies to enhance immune responses and improve clinical outcomes in VL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralLeishmania donovaniCD4-Positive T-LymphocytesT-Lymphocytes, CytotoxicCytotoxicity, ImmunologicHumansGranzymesPerforinFemaleMaleAntigens, Differentiation, T-LymphocyteLysosomal-Associated Membrane Protein 1AdultCell Degranulation

Stichwörter der Autor:innen

CD107aCD4+ T cellscytotoxicitygranzyme Bvisceral leishmaniasis

Substanzen

GranzymesPerforinGNLY protein, humanAntigens, Differentiation, T-LymphocyteLysosomal-Associated Membrane Protein 1GZMB protein, human

Autor:innen und Institutionen

  • Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • QIMR Berghofer Medical Research Institute, Brisbane, Australia.

ORCID-Profile: Shashi Bhushan Chauhan, Shashi Kumar, Vibhav Gautam

Zitieren

APA

Chauhan, S. B., Singh, S. S., Singh, B., Kumar, S., Tiwari, R., Gautam, V., Rivera, F., Nylen, S., Engwerda, C., Sundar, S., & Kumar, R. (2026). Cytotoxic CD4 + T Cells in Visceral Leishmaniasis Patients. Parasite Immunology, 48(8). https://doi.org/10.1111/pim.70097

Vancouver

Chauhan SB, Singh SS, Singh B, Kumar S, Tiwari R, Gautam V, et al. Cytotoxic CD4 + T Cells in Visceral Leishmaniasis Patients. Parasite Immunology. 2026;48(8). doi:10.1111/pim.70097

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Shashi Bhushan and Singh, Siddharth Sankar and Singh, Bhawana and Kumar, Shashi and Tiwari, Rahul and Gautam, Vibhav and Rivera, Fabian and Nylen, Susanne and Engwerda, Christian and Sundar, Shyam and Kumar, Rajiv},
  title = {Cytotoxic CD4 + T Cells in Visceral Leishmaniasis Patients},
  journal = {Parasite Immunology},
  year = {2026},
  volume = {48},
  number = {8},
  doi = {10.1111/pim.70097}
}
Kostenlos starten →